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The effect of strenuous physical activity on the
incidence of benign breast disease and benign
tumours of the female reproductive system is
unknown.
Previous findings of a lower prevalence of breast
cancer and cancers of the reproductive system
among former college athletes compared to non-
athletes (Frisch et al., 1985) suggested that former
athletes and non-athletes might also differ in the
prevalence of benign tumours of these tissues. We
collected detailed medical, reproductive, diet and
activity histories from 5,398 women: 2,622 former
college athletes and 2,776 non-athletes ranging in
age from 21 to 80 yr. We report data on the
prevalence (lifetime occurrence) of benign breast
diseases and benign tumours of the reproductive
system among these women.
Details of the procedures for obtaining rosters of
athletes and non-athletes, the sports included, and
the questions on length and intensity of college,
pre-college and current physical activity have been
previously reported (Frisch et al., 1985).
In addition to the questions on athletics, the 14-
page questionnaire requested detailed medical
history, reproductive history from menarche
through the menopause, including births and
pregnancy outcome, smoking history, current health
problems, height, weight, weight changes, and
current diet.
The questions pertaining to benign tumours were:
1. Did you ever have any of the following medical
procedures?: Breast biopsy, endometrial biopsy
or gynaecological biopsy? If 'yes', for each
biopsy: Age occurred; inpatient or outpatient;
diagnosis; and treatment, if any.
2. Did you ever have a benign tumour(s)? If 'yes':
Age occurred; type or site; and treatment, if any.
The literature on benign breast disease (BBD)
universally mentions the ill-defined nature of BBD,
the wide variety of diseases and non-diseases
included under this rubric and the need for
diagnostic criteria. In the analysis that follows we
defined BBD as at least one benign breast tumour
or at least one breast biopsy (Ernster, 1981; Love et
al., 1982).
The relative risks were adjusted for potential
confounding factors by multiple logistic regression,
using backward selection (Kleinbaum et al., 1982).
In addition to athlete or non-athlete, these factors
included: age, leanness, ever-pregnant, age of
menarche, ever used oral contraceptives (yes/no),
use of hormones for menopausal symptoms
(yes/no), family history of cancer (yes/no), and
smoking (ever/never). For benign breast disease,
ever having had an endometrial biopsy was also
included. Variables are retained in the logistic
model if the significance level is 0.30 or less.
Age of menarche in the logistic regression model
was coded under 12yr, (the reference group), 12-
13yr, and 14yr and over, based on last birthday.
Age of menarche was also asked in terms of years
and months. Relative fatness was estimated by the
equations of Cohn et al., 1980, and Ellis et al., 1974
(see Appendix).
For a given condition, e.g., benign breast disease
(BBD), an individual is counted once, though she
may report more than one benign breast tumour.
Women who reported a benign tumour and/or
disease of more than one site, e.g., breast and
cervix are counted under each site. Women with
breast cancer are excluded from both the
numerator and denominator in calculating rates for
BBD. Women with cancers of the reproductive
system are excluded from both the numerator and
denominator in calculating rates of benign tumours
of the reproductive system.
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Benign Breast Disease (BBD) Non-athletes are at
28% greater risk of BBD than are former college
athletes (Tables 1-111). The relative risk (non-
athlete/athlete), adjusted by multiple logistic
regression, is 1.28, 95% confidence limits (1.05,
1.53). Other significant risk factors, in addition to
non-athlete/athlete, and age, are family history of
cancer in female relatives, and relative fatness.
Having had an endometrial biopsy was a
significant risk factor for BBD: RR =2.04, 95%
confidence limits (1.47, 2.82). Other gynaecological
biopsies were not a significant risk factor for BBD.
Use of oral contraceptives was not significant in
our data, either as a risk factor or a protective
factor.
Of the 533 women who reported BBD, 13 also
reported breast cancer. In comparison, of the 4,865
women who did not have BBD, 56 had breast
cancer. Thus the risk of breast cancer among
women with BBD is 2.1, compared to women with
no previous BBD.
Benign tumours of the reproductive system Table I
shows that the prevalence (lifetime occurrence) rate
Table I Age-specific prevalence (lifetime occurrence) rates of benign diseases
of the reproductive system and of the breast of athletes and non-athletes
Athletes (N=2,622) Non-athletes (N=2,776)
Reproductive Reproductive
systema Breast systemb Breast
Ratel Ratel Ratel Ratel
Age (yr) No. 100 No. 100 No. 100 No. 100
<30 4 0.4 35 3.5 8 1.4 24 4.3
30-39 16 2.4 41 6.3 36 3.3 100 9.2
40-49 20 5.2 54 14.2 33 7.4 58 13.1.
50-59 40 11.9 47 14.2 45 13.0 59 17.6
60-69 14 9.2 25 16.7 37 16.4 50 22.3
70+ 10 12.3 11 14.9 18 19.4 16 18.8
Total 104 4.0 213 8.1 177 6.4 307 11.1
aThe benign tumours of the 104 athletes were: cervix 4, uterus 74, ovary 19,
vagina 7; bThe benign tumours of the 177 non-athletes were: cervix 16, uterus
126, ovary 33, vagina 7. Some women had benign tumours of more than one
site.
Table II Age-adjusted rates per 1,000 and age-adjusted risk ratios (RR) and
95% confidence limits (CL) for benign tumours of the breast and the
reproductive system of former college athletes compared to non-athletes
Age-adjusted rates
+s.e. per 1,000
Athletes Non-athletes RR (95% CL)
Benign breast disease 86.5+5.6 106.3 + 5.7 1.23 (1.04, 1.45)
Benign tumours of the
reproductive system
excluding breast 42.8 +4.0 60.8+4.4 1.42 (1.12, 1.78)
Benign tumours of the
uterus 30.6+3.4 42.6+ 3.6 1.39 (1.05, 1.85)
Benign tumours of the
cervix 2.0+0.9 7.3+ 1.6 3.73 (1.50, 9.25)
Benign tumours of the
ovary 7.8+ 1.8 11.6+2.0 1.50 (0.85, 2.65)LOWER PREVALENCE OF BENIGN TUMOURS 843
Table III Adjusted risk ratios and 95% confidence limits for associations between various risk factors for
benign breast disease and benign tumours of the reproductive systema
Benign All reproductive Benign tumours of:
breast system
Factor disease' (excl. breast)2 Uterus3 Ovary4 Cervix5
Non-athlete/ 1.28 1.45 1.40 1.47 3.43
athlete (1.05, 1.53) (1.12, 1.87) (1.03, 1.89) (0.83, 2.61) (1.14, 10.30)
P=0.19
Age in single 1.04 1.05 1.06 1.03 NS
years (1.03, 1.05) (1.04, 1.06) (1.04, 1.08) (1.01, 1.06)
Family history 1.22 NS NS NS NS
of cancer (yes/no) (1.01, 1.47) P=0.10 P=0.23 P=0.24
Relative fatnessb 0.96 NS NS NS NS
(0.93, 0.99)
Endometrial biopsy 2.04 NA NA NA NA
(yes/no) (1.47, 2.82)
Hormones for NS 2.27 2.31 NS 5.78
menopausal symptoms (1.65, 3.13) (1.60, 3.32) (2.26, 14.78)
(yes/no)
Smoking NS NS 0.76 2.15 2.05
(ever/never) (0.56, 1.03) (1.11, 4.44) (0.77, 5.41)
P=0.07 P=0.15
aBy multiple logistic regression; factors in the model in addition to those in the Table are:
'(a) menarche at 12 or 13, P=0.10; (b) ever-pregnant, P=0.29.
2(a) menarche 14 or over, P=0.13; (b) ever-pregnant, P=0.17; (c) benign breast disease, P=0.24.
3(a) menarche 14 or over, P=0.1 1; (b) ever-pregnant, P=0.15; (c) benign breast disease, P= 0.21.
4(a) ever-pregnant, P=0.21; (b) ever used contraceptives, P=0.12.
5None.
bEstimated by the equations of Cohn et al. (1980) and Ellis et al. (1974).
Numbers in the body of the Table are RRs, 95% CL, and P values if >0.05 and <0.25.
NA: not included in the logistic model.
of benign tumours of the reproductive system
(uterus, cervix, ovary, and vagina) are consistently
lower for athletes than non-athletes. As shown in
Table III, former non-athletes are at 45% greater
risk of benign tumours of the reproductive system
than are former athletes, RR= 1.45, 95%
confidence limits (1.12, 1.87). Age and use of
hormones for menopausal symptoms were also
significant risk factors for these tumours.
The risk ratio for former non-athletes vs. former
athletes for benign tumours of the uterus, which
comprised over two-thirds of all benign tumours of
the reproductive system, excluding breast, is 1.40,
95% confidence limits (1.03, 1.89). Age and use of
hormones for menopausal symptoms were also
significant risk factors for benign tumours of the
uterus. For benign tumours of the uterus the RR
for smoking (ever/never smoked) is 0.76, P=0.07,
95% confidence limits (0.56, 1.03). However,
smoking is a risk factor for benign tumours of the
ovary, RR=2.15, 95% CL (1.11, 4.44). For benign
tumours of the cervix the risk is elevated but not
significant, RR=2.05, 95% CL (0.77, 5.41) P=0.15
(Table III).
This study has shown that women who
participated in athletic activity while in college, and
in the pre-college years, had a lower prevalence
(lifetime occurrence) of benign breast disease and
benign tumours of the reproductive system than did
non-athletic women. These findings are consistent
with our previous findings that former college
athletes had a lower prevalence of malignancies of
the breast and reproductive system than did non-
athletes (Frisch et al., 1985).
Ernster (1981) in her extensive review of the
epidemiology of BBD states that BBD 'however
defined' is a 'very' common condition, and that
perhaps as many as 8-15% of women undergo a
breast biopsy for BBD by the age of 50. Our data,
which are based on self-reports of physician
diagnosed conditions and procedures, including
biopsies, are consistent with the range cited by844 G. WYSHAK et al.
Ernster: the rates of BBD for women 30yr and
over are: 11.1% for former athletes, 13.4% for non-
athletes, and 12.2% for both groups combined.
It is generally accepted that women with a
history of BBD have a two to three fold risk of
breast cancer (Miller & Bulbrook, 1980). Our data
are consistent with this risk; women with BBD were
twice as likely to have breast cancer as those who
did not report BBD.
At present there is no concensus in the literature
about the risk factors for BBD (Ernster, 1981),
perhaps, in part, because of the varying definitions
of benign breast disease. Some investigators believe
that the risk factors for BBD are the same as those
for breast cancer (Bradlow et al., 1983) while others
do not (Soini et al., 1978). We found, in addition to
having been an athlete or a non-athlete, that age
and family history of breast cancer are significant
risk factors, confirming the results of other studies.
We also found a negative association between BBD
and obesity, in accord with previous reports. Breast
cancer studies, however, document the opposite
relation, i.e., a positive association between body
weight and breast cancer (Ernster, 1981). It has
been noted that the negative association of body
weight with BBD may be diagnostic artifact, rather
than obesity being protective (Ernster, 1981). Use
of oral contraceptives was not protective, in accord
with recent reports (Berkowitz et al., 1984).
Ever having had an endometrial biopsy was
significantly associated with BBD, but ever having
other gynaecological biopsies was not. This is a new
finding, as far as we know. This relationship is in
accord with the clinical data of Grattarola (1978)
who reported a greater than expected occurrence of
premenstrual endometrial hyperplasia among
women with BBD, suggesting that BBD is
associated with an endocrine imbalance.
There is little in the literature about risk factors
for benign tumours of the reproductive system, but
our findings are in accord with those on
endometrial cancer and use of hormones for
menopausal symptoms (Lesko et al., 1985).
Our finding of a lower risk of benign tumours of
the uterus among persons who ever smoked, though
not significant at the 0.05 level (P=0.07), is
consistent with the data on endometrial carcinoma
and smoking, suggesting that smoking is protective
(Lesko et al., 1985). The magnitude of the effect we
observed for those who ever smoked vs. those who
never smoked, RR=0.76, is similar to the RR of
0.70 reported for current smokers vs. never smokers
by Lesko et al. (1985). Smoking is a risk factor for
cancer of the uterine cervix (Winkelstein et al.,
1984) and cervical dysplasia, (Harris et al., 1980) in
accord with our findings for benign tumours.
Vessey et al. (1983) have recently reported an
adverse effect of oral contraceptives on cervical
dysplasia, an observation not supported by our
data on benign tumours.
We conclude that former college athletes have a
lower risk of benign diseases of the breast and
other reproductive organs than do non-athletes.
This is a new finding as far as we know. Long-term
differences in diet, physical activity and relative
leanness are associated with an athletic life-style
(Frisch et al., 1985). As was suggested by their
lower risk of sex hormone sensitive cancers (Frisch
et al., 1985), the decreased risk of former college
athletes may be associated with a decrease in the
extraglandular conversion of androgen to oestrogen
(Siiteri, 1981), and with the metabolism of
oestrogen to less potent forms, which is associated
with increased leanness (Fishman et al., 1975).
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Appendix
Predictions of body composition by equations of Cohn et
al. (1980) and Ellis et al. (1974).
*Predicted potassium, Kp=aW0 5Ht2
W=weight (kg)
Ht=height (metres)
a (for females)=4.58-0.10 age (y).
Lean body mass (LBM) (for females) =Kp x 0.442kg.
Fat (kg) =body weight (kg) -LBM (kg).
%Fat =Fat/body weight.
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